Latest information on COVID-19

Excellence in Scientific Discovery

The Institute's comprehensive investigations extend from the earliest phase of basic discovery to the development of new cancer diagnostics, treatment protocols and prevention strategies

Research Programs

Basic, clinical and translational studies into the biology of cancer and the factors that contribute to its onset and growth.


Shared Resources

The most sophisticated technologies and research protocols are offered to SCI members through a number of core facilities.


Key Initiatives

Inter-disciplinary teams of collaborative investigators partner to foster discovery, application and translation of scientific knowledge.


Institute Membership

Scientists and physicians from a wide range of disciplines, all dedicated to reducing the burden of cancer.


News & Publications

Publications, press releases and news are shared with scientists, physicians, patients and friends of the Institute.


Funding Opportunities

Internal and external sources of support for both established cancer research programs and promising new ideas.  


Clinical Trial Support

The Cancer Clinical Trials Office provides regulatory and administrative services to SCI members conducting clinical trials.  


Training Opportunities

Education and professional development designed to train the next generation of cancer researchers and physicians.



National Cancer Institute Designation

News & Publications

  • ‘Remote-controlled’ CAR-T cell therapy safer

    Stanford researchers modified anti-cancer CAR-T cells so they can be controlled with an oral drug. The modified cells are safer, more potent and more active against solid tumors in mice.

  • New therapies for rare blood cancer

    Hematologist Jason Gotlib wanted more effective treatments for patients with systemic mastocytosis. His research has led to the approval of two new treatments by the Food and Drug Administration.

  • Key molecule’s structure found at last

    The structure of a critical cellular-signaling molecule has finally been discovered by Stanford researchers. The finding may lead to new therapies.